Search research articles
Contact Us
Filters
Showing results (81-90 of 141) with videos related to
Page
of 15
Sort By:
Nature Genetics
|
May 13, 1999
Evolution of neoplastic cell lineages in Barrett oesophagus
M T Barrett, C A Sanchez, L J Prevo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 13, 2011
Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas
Sherry Lee, Kelly G Paulson, Elizabeth P Murchison, et al.
Nature Communications
|
February 25, 2018
Evolution of Barrett's esophagus through space and time at single-crypt and whole-biopsy levels
Pierre Martinez, Diego Mallo, Thomas G Paulson, et al.
Plos One
|
December 2, 2008
p16 mutation spectrum in the premalignant condition Barrett's esophagus
Thomas G Paulson, Patricia C Galipeau, Lianjun Xu, et al.
Journal of the American Academy of Dermatology
|
July 25, 2020
Clinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patients
Neha Singh, Nora A Alexander, Kristina Lachance, et al.
The Journal of Investigative Dermatology
|
November 30, 2012
Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage
Kelly G Paulson, Jayasri G Iyer, Astrid Blom, et al.
Obstetrics and Gynecology International
|
November 28, 2013
Feasibility of RNA and DNA extraction from fresh pipelle and archival endometrial tissues for use in gene expression and SNP arrays
Heather D Kissel, Thomas G Paulson, Karen Liu, et al.
American Journal of Clinical Pathology
|
November 15, 2013
p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility
Galina Y Stetsenko, Jacqueline Malekirad, Kelly G Paulson, et al.
The Lancet. Oncology
|
September 11, 2025
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
Kelly G Paulson, Sally C M Lau, Myung-Ju Ahn, et al.
Cancer Research
|
October 21, 2010
Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients
Kelly G Paulson, Joseph J Carter, Lisa G Johnson, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 141) with videos related to
Sort By:
Page
of 15
Nature Genetics
|
May 13, 1999
Evolution of neoplastic cell lineages in Barrett oesophagus
M T Barrett, C A Sanchez, L J Prevo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 13, 2011
Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomas
Sherry Lee, Kelly G Paulson, Elizabeth P Murchison, et al.
Nature Communications
|
February 25, 2018
Evolution of Barrett's esophagus through space and time at single-crypt and whole-biopsy levels
Pierre Martinez, Diego Mallo, Thomas G Paulson, et al.
Plos One
|
December 2, 2008
p16 mutation spectrum in the premalignant condition Barrett's esophagus
Thomas G Paulson, Patricia C Galipeau, Lianjun Xu, et al.
Journal of the American Academy of Dermatology
|
July 25, 2020
Clinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patients
Neha Singh, Nora A Alexander, Kristina Lachance, et al.
The Journal of Investigative Dermatology
|
November 30, 2012
Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage
Kelly G Paulson, Jayasri G Iyer, Astrid Blom, et al.
Obstetrics and Gynecology International
|
November 28, 2013
Feasibility of RNA and DNA extraction from fresh pipelle and archival endometrial tissues for use in gene expression and SNP arrays
Heather D Kissel, Thomas G Paulson, Karen Liu, et al.
American Journal of Clinical Pathology
|
November 15, 2013
p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utility
Galina Y Stetsenko, Jacqueline Malekirad, Kelly G Paulson, et al.
The Lancet. Oncology
|
September 11, 2025
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b study
Kelly G Paulson, Sally C M Lau, Myung-Ju Ahn, et al.
Cancer Research
|
October 21, 2010
Antibodies to merkel cell polyomavirus T antigen oncoproteins reflect tumor burden in merkel cell carcinoma patients
Kelly G Paulson, Joseph J Carter, Lisa G Johnson, et al.
Page
of 15